Condition: Chronic Subdural Hematoma · Sponsor: Region Skane
The SWEMMA trial is an open, national, multi-center, prospective, randomized (1:1), superiority trial designed to assess impact on reoperation rates for chronic subdural hematoma with a head-to-head comparison of embolization of the middle meningeal artery (intervention) with standard neurosurgical hematoma evacuation (control).
This description comes directly from the study's public registry record.
Åke Holmberg · +46739660740 · ake.holmberg@regionstockholm.se
Johan Wassélius, MD, PhD · johan.wasselius@gmail.com
Always discuss trial participation with your own doctor first.
| Sahlgenska University Hospital | Gothenburg, Sweden | Not Yet Recruiting |
| Skåne University Hospital | Lund, Sweden | Recruiting |
| Karolinska Hospital | Stockholm, Sweden | Not Yet Recruiting |
| Norrlands Universitetssjukhus | Umeå, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05267184